PF-33195 |
KETOPROFENO Genfar 2.5 % gel topico |
2009-07-20 |
|
Laboratorios Genericos Farmaceuticos S A Genfar S. A. |
Colombia
|
Bodega Farmacéutica S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-33196 |
Trimetoprim-Sulfametoxazol Genfar 40-200 mg/5 mL suspension oral |
2009-07-20 |
|
Laboratorios Genericos Farmaceuticos S A Genfar S. A. |
Colombia
|
Bodega Farmacéutica S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-33231 |
YODOPOVIDONA Genfar 8% Espuma tópica |
2019-07-22 |
|
Laboratorios Genericos Farmaceuticos S A Genfar S. A. |
Colombia
|
Sanofi-Aventis De Guatemala |
Agencias J.I. Cohen |
DASA |
Droguería Y Farmacia Lanquetin |
Bodega Farmacéutica, S.A. |
Agefinsa (Agencia Farm. Intern., S.A.) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-33332 |
METOCLOPRAMIDA Genfar 4 mg/mL Solucion oral |
2014-07-28 |
|
Laboratorios Genericos Farmaceuticos S A Genfar S. A. |
Colombia
|
Bodega Farmacéutica S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-33333 |
BETAMETASONA Genfar 0.05 % Unguento topico |
2009-07-28 |
|
Laboratorios Genericos Farmaceuticos S A Genfar S. A. |
Colombia
|
Bodega Farmacéutica S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-34348 |
SIBUTRAMINA Genfar 15 mg cápsulas |
2014-11-10 |
|
Laboratorios Genericos Farmaceuticos S A Genfar S. A. |
Colombia
|
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-25951 |
Metronidazol Gen Far 250 mg Tabletas |
2006-04-18 |
|
Dorothy Haydée Fuentes Perdomo De Gándara |
Colombia
|
Bodega Farmacéutica S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-25950 |
Metronidazol 125 mg |
2006-04-18 |
|
Dorothy Haydée Fuentes Perdomo De Gándara |
Colombia
|
Bodega Farmacéutica S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-24363 |
KETOCONAZOL Genfar 100 mg/5mL Suspension oral |
2006-11-29 |
|
Laboratorios Genericos Farmaceuticos S.A. (Genfar) |
Colombia
|
Bodega Farmacéutica S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-24678 |
TIAMINA Genfar 300 mg. Tabletas |
2007-02-04 |
|
Laboratorios Genericos Farmaceuticos S.A. (Genfar) |
Colombia
|
Bodega Farmacéutica S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|